Clinical Trials Directory

Trials / Completed

CompletedNCT07095270

Evaluation of Circadian OS Technology on Melatonin Suppression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Accepted

Summary

Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based light intervention influences sleepiness as measured objectively via suppression of melatonin and subjectively via the Karolinska Sleepiness scale.

Detailed description

Aims: To test whether the Circadian OS app delivers sufficient circadian effective light that will result in measurable melatonin suppression (target suppression is 30% after 1 hour exposure) Hypothesis: The Circadian OS app will deliver a Circadian Stimulus (CS) of 0.3 at the eye level and will result in 30% melatonin suppression after one hour using the device compared to less than 10% suppression without the Circadian OS app and the subjects will feel less sleepy (KSS score) when exposed to the Circadian OS app compared to no app Outcomes: melatonin suppression will be calculated from saliva samples and subjective sleepiness as self-rated on the Karolinska Sleepiness Scale (KSS)

Conditions

Interventions

TypeNameDescription
DEVICECircadian OS softwareCircadian OS is a software program that runs on existing iPads. It utilizes the iPad capabilities to control and deliver circadian-effective light.

Timeline

Start date
2025-07-07
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-07-31
Last updated
2026-01-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07095270. Inclusion in this directory is not an endorsement.